Skip to content
HowShorted

ADIAL PHARMACEUTICALS, INC. short interest in 2024

In 2024, ADIAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 3.05% of shares outstanding on 12 Jan 2024 to 2.73% on 15 Nov 2024, a change of -0.32 percentage points. The year's high was 24.90% on 15 Apr 2024 and its low 0.80% on 15 Oct 2024, averaging 4.48% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.98 days on 15 Jul 2024. Full history: ADIAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ADIAL PHARMACEUTICALS, INC. in 2024

2024 in figures

Start of year
3.05% (12 Jan 2024)
End of year
2.73% (15 Nov 2024)
Change
-0.32 pp
High
24.90% (15 Apr 2024)
Low
0.80% (15 Oct 2024)
Average
4.48%
Highest days to cover
2.98 (15 Jul 2024)
SEC filings marked
4

Every report in 2024

ADIAL PHARMACEUTICALS, INC. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20243.05%1.00
31 Jan 20241.80%1.25
29 Feb 20242.31%1.00
15 Apr 202424.90%1.0010-K filed
15 May 20243.13%1.0010-Q filed
31 May 20243.86%1.28
14 Jun 20245.15%1.00
28 Jun 20243.86%1.55
15 Jul 20243.61%2.98
31 Jul 20246.95%1.00
15 Aug 20244.98%1.5310-Q filed
30 Aug 20244.26%1.85
13 Sep 20242.29%1.16
30 Sep 20241.22%1.00
15 Oct 20240.80%1.00
31 Oct 20241.23%1.00
15 Nov 20242.73%1.0010-Q filed

See also: ADIAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.